Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Diabetic Foot Ulcer
100%
Leg Ulcer
100%
Foot Ulcer
100%
Mediator
100%
Host Resistance
100%
Patient with Type 2 Diabetes
100%
Wound Fluid
85%
Lipopolysaccharide
71%
Chronic Wound
57%
Interleukin 10
42%
Granulocyte Colony Stimulating Factor
42%
Vasculotropin
42%
Wound Healing
28%
Wound
28%
Donor Site
28%
Sphingolipid Activator Protein 2
28%
Innate Immunity
14%
Split Thickness Skin Graft
14%
Antiinfective Agent
14%
Wound Infection
14%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
100%
S100A8
100%
Host Defense
100%
Venous Leg Ulcer
87%
Wound Fluid
75%
Diabetic Foot Ulcer
75%
Lipopolysaccharide
62%
Chronic Wounds
50%
Interleukin-10
37%
Granulocyte Colony-stimulating Factor (G-CSF)
37%
Vascular Endothelial Growth Factor
37%
Non-healing
25%
Donor Site Wound
25%
Antimicrobial
12%
Standardized Method
12%
Immunomodulating
12%
Innate Immune Response
12%
Patient Serum
12%
Split-thickness Skin Graft
12%
Limulus Amebocyte Lysate Assay
12%
Quantitative Assay
12%
Protein Alteration
12%
Healing Wounds
12%
Fluid Level
12%
Pathophysiological Mechanisms
12%
Factor Level
12%
Inducer
12%
Infected Wound
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclorphan
100%
Foot Ulcer
100%
Non Insulin Dependent Diabetes Mellitus
100%
Wound
100%
Leg Ulcer
100%
Lipopolysaccharide
71%
Chronic Wound
57%
Vasculotropin
42%
Granulocyte Colony Stimulating Factor
42%
Interleukin 10
42%
Sphingolipid Activator Protein 2
28%
Wound Healing
28%
Wound Infection
14%
Limulus
14%
Antiinfective Agent
14%
Immunology and Microbiology
Mediator
100%
Host Resistance
100%
Foot
100%
Leg
87%
Wound Fluid
75%
Vasculotropin
37%
Interleukin 10
37%
Granulocyte Colony-Stimulating Factor
37%
Wound Healing
25%
Innate Immune System
12%
Limulus
12%
Cell Lysate
12%